| Apidra |
021629 |
003 |
351(a) |
insulin glulisine |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2009/02/24
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Atryn |
125284 |
001 |
351(a) |
Antithrombin (Recombinant) |
For Injection |
Intravenous |
1750IU |
Single-Dose Vial |
2009/02/06
|
rEVO Biologics, Inc. |
Disc |
Voluntarily Revoked |
|
N/A |
| Riastap |
125317 |
001 |
351(a) |
Fibrinogen Concentrate (Human) |
For Injection |
Intravenous |
900-1300MG |
Single-Dose Vial |
2009/01/16
|
CSL Behring GmbH |
Rx |
Licensed |
|
N/A |
| Cinryze |
125267 |
001 |
351(a) |
C1 Esterase Inhibitor (Human) |
For Injection |
Intravenous |
500U |
Single-Dose Vial |
2008/10/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Novolog Mix 50/50 |
021810 |
001 |
351(a) |
insulin aspart protamine and insulin aspart |
Injectable Suspension |
Subcutaneous |
150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML) |
Multi-Dose Cartridge |
2008/08/26
|
Novo Nordisk Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Novolog Mix 50/50 |
021810 |
002 |
351(a) |
insulin aspart protamine and insulin aspart |
Injectable Suspension |
Subcutaneous |
150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML) |
Autoinjector |
2008/08/26
|
Novo Nordisk Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Omnitrope |
021426 |
004 |
351(a) |
somatropin |
Injection |
Subcutaneous |
10MG/1.5ML |
Multi-Dose Cartridge |
2008/08/25
|
Sandoz Inc. |
Rx |
Licensed |
N/A |
N/A |
| Nplate |
125268 |
001 |
351(a) |
romiplostim |
For Injection |
Subcutaneous |
250MCG |
Single-Dose Vial |
2008/08/22
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Nplate |
125268 |
002 |
351(a) |
romiplostim |
For Injection |
Subcutaneous |
500MCG |
Single-Dose Vial |
2008/08/22
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kinrix |
125260 |
001 |
351(a) |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine |
Injection |
Intramuscular |
0.5ML |
Single-Dose Vial |
2008/06/24
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Pentacel |
125145 |
001 |
351(a) |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine |
Injection |
Intramuscular |
0.5ML |
Single-Dose Vial |
2008/06/20
|
Sanofi Pasteur Limited |
Rx |
Licensed |
|
N/A |
| PegIntron/ Rebetol Combo Pack |
125196 |
001 |
351(a) |
peginterferon alfa-2b and ribavirin |
|
|
50MCG/0.5ML & 200MG |
|
2008/06/13
|
Schering Corporation a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| PegIntron/ Rebetol Combo Pack |
125196 |
002 |
351(a) |
peginterferon alfa-2b and ribavirin |
|
|
80MCG/0.5ML & 200MG |
|
2008/06/13
|
Schering Corporation a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| PegIntron/ Rebetol Combo Pack |
125196 |
003 |
351(a) |
peginterferon alfa-2b and ribavirin |
|
|
120MCG/0.5ML & 200MG |
|
2008/06/13
|
Schering Corporation a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| PegIntron/ Rebetol Combo Pack |
125196 |
004 |
351(a) |
peginterferon alfa-2b and ribavirin |
|
|
150MCG/0.5ML & 200MG |
|
2008/06/13
|
Schering Corporation a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Recothrom |
125248 |
002 |
351(a) |
Thrombin topical (Recombinant) |
For Solution |
Topical |
20000IU |
Single-Dose Vial |
2008/05/23
|
Baxter Healthcare Corporation |
Rx |
Licensed |
|
N/A |
| Novoseven, Novoseven Rt |
103665 |
004 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
5.0MG |
Single-Dose Vial |
2008/05/09
|
Novo Nordisk Inc. |
Rx |
Licensed |
|
N/A |
| Novoseven, Novoseven Rt |
103665 |
005 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
1.0MG |
Single-Dose Vial |
2008/05/09
|
Novo Nordisk Inc. |
Rx |
Licensed |
|
N/A |
| Novoseven, Novoseven Rt |
103665 |
006 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
2.0MG |
Single-Dose Vial |
2008/05/09
|
Novo Nordisk Inc. |
Rx |
Licensed |
|
N/A |
| Cimzia |
125160 |
001 |
351(a) |
certolizumab pegol |
For Injection |
Subcutaneous |
200MG |
Single-Dose Vial |
2008/04/22
|
UCB, Inc. |
Rx |
Licensed |
N/A |
N/A |